![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 10, 7321-7326, March 10, 2000
From the Department of Biological Chemistry, Faculty of
Agriculture, Yamaguchi University, Yamaguchi 753-8515, Japan
Several mutants of quinoprotein glucose
dehydrogenase (GDH) in Escherichia coli, located around its
cofactor pyrroloquinoline quinone (PQQ), were constructed by
site-specific mutagenesis and characterized by enzymatic and kinetic
analyses. Of these, critical mutants were further characterized after
purification or by different amino acid substitutions. H262A mutant
showed reduced affinities both for glucose and PQQ without significant
effect on glucose oxidase activity, indicating that His-262 occurs very
close to PQQ and glucose, but is not the electron acceptor from
PQQH2. W404A and W404F showed pronounced reductions of
affinity for PQQ, and the latter rather than the former had equivalent
glucose oxidase activity to the wild type, suggesting that Trp-404 may
be a support for PQQ and important for the positioning of PQQ. D466N,
D466E, and K493A showed very low glucose oxidase activities without
influence on the affinity for PQQ. Judging from the enzyme activities
of D466E and K493A, as well as their absorption spectra of PQQ during glucose oxidation, we conclude that Asp-466 initiates glucose oxidation
reaction by abstraction of a proton from glucose and Lys-493 is
involved in electron transfer from PQQH2.
PQQ1 is a non-covalently
bound prosthetic group of most quinoprotein dehydrogenases in
Gram-negative bacteria, which are involved in the oxidation of alcohols
or aldose sugars in their periplasm (1).
Membrane-bound quinoprotein GDH of Escherichia coli
catalyzes oxidation of the C-1 hydroxyl group of the pyranose form of D-glucose to D-glucono- Three-dimensional structures of MDHs from three different bacteria have
been determined by x-ray crystallography (10-12), which reveals that
the Alignment of the PQQ-binding proteins or subunits among quinoprotein
dehydrogenases reveals that the periplasmic domain of GDH in E. coli has 26% sequence similarity to the To examine that assumption, we targeted the amino acid residues
surrounding the reactive site of PQQ in the model. Several mutants were
constructed by site-specific mutagenesis on the targeted residues and
characterized by kinetic and spectral analyses. In comparison with
other complex dehydrogenases with several subunits in respiratory
chains (22-26), a single protein GDH would be a good model to
elucidate the molecular mechanism of catalytic reactions or
intramolecular electron transfer. Here, we provide several lines of
evidence for the molecular functions of the amino acid residues
proposed in the active site of the model GDH. We also present a
catalytic reaction mechanism of GDH based on that proposed for MDH (13,
27).
Materials--
All restriction enzymes, T4 DNA
ligase, and Taq DNA polymerase were purchased from Takara
Shuzo (Kyoto, Japan). Oligonucleotide primers for site-specific
mutagenesis were purchased from Sawady Technology (Tokyo, Japan). Q-2
was kindly supplied by Eizai Co., Ltd. (Tokyo, Japan). All other
chemicals were of analytical grade and obtained from commercial sources.
Bacterial Strains and Plasmids--
The bacterial strains used
in this study were derivatives of E. coli K-12. Their
relevant genotype and plasmids are listed in Table I.
Mutagenesis--
To construct all mutants of GDH, site-specific
mutagenesis was carried out using the Mutan-Super Express Km kit
(Takara Shuzo, Japan). Mutagenic primers used were:
5'-CTTTCCAGgccGTAACCTG-3' for H262A, 5'-CAAACTCCgcgGCACCAGC-3' for
W404A, 5'-CAAACTCCtttGCACCAGC-3' for W404F, 5'-CGATTGCCgccCCAATGGC-3'
for N607A, 5'-CTCCGGCGgcaACCGGCAA-3' for K493A,
5'-CTCCGGCGcgtACCGGCAA-3' for K493R, 5'-ACCTGTGGgccATGGATCTT-3' for
D466A, 5'-ACCTGTGGaacATGGATCTT-3' for D466N, and
5'-ACCTGTGGgaaATGGATCTT-3' for D466E.
PCR of 30 cycles for site-specific mutagenesis was performed by using a
Takara PCR Thermal Cycler MP; each cycle consisted of denaturation at
94 °C for 1 min, annealing at 55 °C for 1 min, and extension at
72 °C for 5 min. The PCR products were recovered by ethanol
precipitation after phenol extraction and introduced into MV1184.
Kanamycin-resistance mutants were isolated, and mutation positions were
confirmed by nucleotide sequencing (28) using the Thermo Sequenase
cycle sequencing kit (Amersham Pharmacia Biotech). Conventional
recombinant DNA techniques (29) were used for exchanging the mutated
regions with the corresponding in pUCGCD1 bearing the wild-type GDH
gene. The recombined mutant plasmids and their mutation positions were
reconfirmed by restriction mapping and by DNA sequencing. Expression of
GDH mutants was examined by SDS-polyacrylamide gel electrophoresis,
followed by Western blotting using a polyclonal antibody raised against
E. coli GDH as described previously (30).
Preparation of Membrane Fractions and Purification of Mutant
GDHs--
Cells harboring the wild-type plasmid, pUCGCD1, or mutant
pUCGCDs were grown in LB (1% Bacto-tryptone, 0.5% yeast extract, and
0.5% NaCl) medium containing ampicillin (100 µg/ml) for 14 h at
37 °C. Membrane fractions were then prepared according to the
procedure described previously (4). Critical mutant GDHs as well as the
wild-type GDH were purified according to the procedure described (4,
19). For W404A mutant, all purification steps were performed in the
presence of 0.1 µM PQQ to stabilize enzyme activity.
Purified enzymes were analyzed by SDS-polyacrylamide gel
electrophoresis to confirm their homogeneity.
Enzyme Assay and Analytical Procedures--
PMS reductase
activity and glucose oxidase activity (glucose oxidase respiratory
chain activity) were measured as described (4, 31) except that instead
of 10 mM KPB (pH 7.0), 5 mM MOPS (pH 7.0) was
used as the assay buffer for purified enzyme in Table III. Note that
PMS reductase activity with 5 mM MOPS (pH 7.0) was found to
be about 2 times higher than that with 10 mM KPB (pH 7.0),
reported previously (19). Q-2 reductase activity was measured at
25 °C by the addition of 33 mM glucose and 30 µM Q-2 in 5 mM MOPS (pH 7.0) after 20 min
preincubation in the presence of 1 µM PQQ, 0.5 mM MgCl2, and 0.025% Tween 20. One unit of PMS
reductase and Q-2 reductase activities are defined as 1 µmol of
2,4-dichlorophenol indophenol and Q-2, respectively, reduced/min, both
of which correspond to 1 µmol of glucose oxidized/min. One unit of
glucose oxidase activity is defined as 1 microatom of oxygen
consumed/min, which is equivalent to 1 µmol of glucose oxidized/min.
Km values were estimated on the basis of the
Lineweaver-Burk plot. Protein content was determined according to the
Dulley and Grieve method (32) using bovine serum albumin as a standard.
Occurrence of the reduced form of PQQ during the catalytic reaction was
examined by taking the absolute absorption spectra of purified
apo-forms (4.5 µM each) of the wild-type and three mutant
GDHs in 5 mM MOPS (pH 7.0) containing 0.1% alkylglucoside
on a Shimadzu spectrophotometer (Multispec-1500). Spectra were then
taken after holoenzyme formation, which was performed by incubation
with 4.5 µM PQQ and 0.5 mM MgCl2 for 20 min at 25 °C, and subsequently spectra were taken after the
addition of 33 mM glucose to the holoenzyme.
Stability and Characteristics of Mutant GDHs in Membrane
Fractions--
In order to examine the functions of the amino acid
residues located close to the active site of the model GDH (Fig.
1), several substitutions were introduced
into it by site-specific mutagenesis. The plasmid clones of the mutants
and their mutation sites were shown in Table
I. The stability and expression level of
mutant GDH proteins were checked by Western blot analysis (Fig.
2). It revealed that contents of the
mutant GDHs in the membrane fractions were 70-90% of that of the wild
type except for D466A and W404A. The contents of the latter two mutants
were about 10% and 40%, respectively, indicating that both GDH
molecules may be unstable and presumably susceptible to intracellular
proteolytic degradation.
Characteristics of the mutant GDHs were defined by the PMS reductase
and glucose oxidase activities of the membrane fractions (Table
II), which were calculated based on their
relative GDH contents in the fractions estimated by Western blot
analysis (Fig. 2). These activities and Km values
for PQQ and glucose were compared with those of the wild type.
Moreover, some of the critical mutants were characterized after
purification (Table III). Q-2 reductase
activity was measured with the purified mutant GDHs, which may reflect
the ability of intramolecular electron transfer. The
Km values for PQQ and glucose of the purified mutant
GDHs were found to be nearly the same as those observed in the membrane
fractions as shown in Table II. The K493A and D466E mutant GDHs showed
very low Q-2 reductase activities compared with the wild type, which is
consistent with the results of glucose oxidase activity observed in the
membrane fractions.
Functions of His-262 and Trp-404--
In the model GDH, PQQ was
proposed to be sandwiched between Trp-404 on the lower side and His-262
on the upper side. As the disulfide ring in MDH of M. extorquens was proposed to play a role in electron transfer
reaction (17), His-262 in GDH, being at the corresponding position to
the ring, was postulated to act as an electron acceptor. The H262A
mutation was found to have no significant effect on PMS reductase and
glucose oxidase activities, but its affinities for glucose and PQQ were
decreased about 11- and 8-fold, respectively, compared with those of
the wild-type GDH in the membrane fractions (Table II). These results
suggest that His-262 is not an electron acceptor from
PQQH2, but it may be located very close to PQQ and glucose
molecules at the active site. Recently, a similar conclusion has been
drawn for the H262Y mutant by Cozier et al. (21).
The W404A showed a pronounced reduction of affinity for PQQ and very
low PMS reductase and glucose oxidase activities compared with the wild
type (Table II). The lower activity is probably because the alanine
molecule may be too small as a lower planer support for PQQ. We thus
constructed and tested another mutant, W404F. This mutant was found to
have relatively higher activities of PMS reductase and glucose oxidase
than W404A, although it showed extremely low affinity for PQQ (Table
II). The substitution from Trp to Ala at position 404 may cause a local
structural change, which influences the accessibility of PQQ or the
positioning of PQQ in the catalytic site. Since W404F had nearly the
equivalent glucose oxidase activity to that of the wild type, the Phe
residue may be exchangeable with the Trp residue at least as a support for PQQ. Therefore, Trp-404 is assumed to be very close to PQQ and to
confer a support for PQQ, which may be important for the positioning of
PQQ as proposed previously (13). Notably, W404F was found to have very
weak activity of PMS reductase but still retained glucose oxidase
activity equivalent to that of the wild type (Table II). It is likely
that somehow this mutation has weakened the electron transfer to
PMS.
Amino Acid Residues Close to the C-4 and C-5 Carbonyls of
PQQ--
There are many equatorial interactions between substituent
groups of PQQ and amino acid residues in the model GDH (13). In the
active site of GDH, the PQQ ligation to Ca2+ or
Mg2+ may be nearly the same as in MDH (18), but the
ligation to the protein would be different from that in MDH. It was
proposed that Asn-607 is equatorially interacting with C-4 and Lys-493 interacting with C-4 and C-5 of PQQ, and Asp-466 is a possible residue
involved in the initial proton abstraction reaction from glucose (13).
In order to clarify the catalytic reaction mechanism, substitutions
were performed on these three residues, Asn-607, Lys-493, and Asp-466
of GDH.
The model GDH showed that the amide group of Asn-607 makes a hydrogen
bond interaction with the C-4 carbonyl of PQQ (13). However, the N607A
mutant showed only slightly reduced activities of PMS reductase and
glucose oxidase without significant effect on the affinity for PQQ
(Table II). Therefore, it is unlikely that Asn at the position 607 is a
crucial residue for the catalytic reaction or the stabilization of PQQ
in the active site.
The K493A and K493R mutants were found to have very low activities of
both PMS reductase and glucose oxidase in the membrane fractions
compared with the wild type (Table II), and purified K493A also showed
very low Q-2 reductase activity (Table III). K493A seemed to have no
effect on the affinity for PQQ but K493R showed a pronounced reduction
of affinity for PQQ (Table II). These results suggest that the positive
charge of Lys may be crucial for reactivity, but the alteration from
Lys to Arg at position 493 may cause a local structural change,
resulting in extremely low glucose oxidase activity as well as low
affinity for PQQ. Since Arg occurs in MDH at the corresponding position
to Lys-493 in GDH, the distance between Lys-493 and C-4 and/or C-5
carbonyl oxygen might be important.
Asp-466 was replaced with Asn or Glu. The resultant D466N and D466E
were shown to have very low PMS reductase and glucose oxidase
activities in the membrane fractions without influences on the affinity
for PQQ (Table II). Purified D466E also showed extremely low Q-2
reductase activity, but almost no effect on the affinity for PQQ (Table
III). In addition, both D466N and D466E exhibited decreased affinities
for glucose (Table II). These results suggest that Asp-466 may be
located near the glucose molecule at the active site and important for
the catalytic reaction. It is also suggested that Asp at position 466 is not exchangeable with Glu, presumably due to the restricted distance
between Asp-466 and the C-1 hydroxyl group of glucose.
Since D730N was demonstrated previously as a crucial residue in the
catalytic reaction (19), the mutant GDH was also purified and
characterized (Table III). Its low PMS reductase and Q-2 reductase activities seemed to be consistent with the previous results, showing
low PMS reductase, glucose oxidase, and ubiquinone-1-reductase activities in the membrane fractions.
Judging from those results described above, at least Asp-466, Lys-493,
and Asp-730 appeared to be crucial for a successive process of
catalytic reactions from glucose oxidation to ubiquinone reduction. In
order to further clarify their functions and positions in the catalytic
cycle, we took the absolute absorption spectra of the purified apo- and
holo-forms of the wild-type and mutant GDHs, and also followed changes
of their spectra after the addition of glucose. As seen in Fig.
3, PQQ in the wild type could be almost completely reduced within 10 s after the addition of glucose to the holo-enzyme solution, while only 50% or less reduction of PQQ were
observed within 10 s in the case of K493A or D730N. By contrast,
negligible reduction of PQQ was found in D466E even 60 min after
glucose addition. These results clearly suggest that Asp-466 is
involved in a catalytic reaction before PQQ reduction while Lys-493 and
Asp-730 perform their functions at the steps after PQQ reduction. The
slow and gradual reduction of PQQ in the K493A or D730N mutants may be
due to changes of the local structure near the reactive site of PQQ by
these mutations. Alternatively, such mutations influenced the
pK value of Asp-466 as postulated in MDH (33), which led to
a decrease in the reaction rate.
Putative Catalytic Reaction Mechanism of GDH in E. coli--
Two
types of mechanism have been proposed in the case of MDH for the
initial proton-abstraction reaction from methanol: 1) a reaction
mechanism via a covalent hemiketal intermediate and 2) a reaction
mechanism by a hydride transfer (34, 35). At least two lines of
evidence supporting the former mechanism have been reported (34,
36).
Fig. 4 shows a putative catalytic
reaction mechanism of E. coli GDH involving a hemiketal
intermediate, where a negatively charged residue Asp-466 acts as a
base, which initiates the oxidation reaction by abstraction of a proton
from glucose. The proton abstraction leads to an oxyanion form of
substrate, which attacks the electrophilic C-5 of PQQ, giving the
hemiketal intermediate. The subsequent reaction leads to production of
PQQH2 and release of glucono-
On the other hand, this and previous data (19) indicated that mutants
at position 730 reduced the GDH activity but D730N still retained the
ability of PQQH2 formation. Therefore, Asp-730 seems to be
involved in the step between PQQH2 and ubiquinone. Its
function, however, is not clear because Asp-730 is not present in the
active site of the model GDH proposed by Cozier and Anthony (13).
We thank Dr. H. Toyama for helpful
discussion. We also thank Dr. C. Anthony for giving us permission to
use the figure of the model GDH structure.
*
This work was supported in part by a grant-in-aid from the
Ministry of Education, Science and Culture of Japan.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The abbreviations used are:
PQQ, pyrroloquinoline quinone;
GDH, glucose dehydrogenase;
MDH, methanol
dehydrogenase;
Q-2, ubiquinone-2, PCR, polymerase chain reaction;
PMS, phenazine methosulfate;
MOPS, 3-(N-morpholino)propanesulfonic acid;
KPB, potassium
phosphate buffer.
Functions of Amino Acid Residues in the Active Site of
Escherichia coli Pyrroloquinoline Quinone-Containing Quinoprotein
Glucose Dehydrogenase*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
-lactone, which is
spontaneously converted to D-gluconate, and concomitantly
transfers electrons to ubiquinol oxidase through ubiquinone in the
respiratory chain (2, 3). Topological analysis revealed that the
monomeric GDH possesses five trans-membrane segments at the N-terminal
portion (residues 1-154), which ensure strong anchorage of the protein
in the inner membrane (4). The remaining C-terminal portion (residues
155-796) occurs at the periplasmic side of the membrane. This portion
is assumed to have a catalytic domain including PQQ (5, 6) and
Ca2+ or Mg2+ binding sites (7, 8). Moreover,
GDH of E. coli occurs as an apoenzyme (7, 8), and the
exogenous addition of PQQ with the divalent cation leads to formation
of the active enzyme (9).
subunit is a superbarrel made up of eight topologically identical four stranded anti-parallel
sheets, being arranged with
radial symmetry like the blades of a propeller. PQQ is tightly stacked
within a chamber of the active site in the
subunit, and
Ca2+ helps PQQ to be maintained in the correct
configuration. Amino acid residues interacting with PQQ and
Ca2+ are dispersed in the whole
subunit.
subunit of MDH in
Methylobacterium extorquens (13). On the basis of the superbarrel structure of the
subunit of MDH, a model structure of
GDH was proposed except for its N-terminal trans-membrane domain and
several unique segments lacking in MDH (13). The proposed model
depicted the possible amino acid residues interacting with PQQ in the
catalytic domain of GDH (Fig. 1). A key feature of PQQ structure is
ortho-quinone at the C-4 and C-5 positions, which becomes
reduced to the quinol during catalysis (14, 15). In the oxidized state,
the C-5 carbonyl is very reactive toward nucleophiles such as alcohols,
ammonia, amines, cyanide, and amino acids (15, 16). The PQQ in GDH is
proposed to be sandwiched between Trp-404 and His-262 by analogy with
the MDH structure in M. extorquens (13), where PQQ is
tightly stacked between Trp-243 and a novel disulfide ring composed of
Cys-103 and Cys-104 (17). In addition to such vertical interactions
with PQQ, there are many equatorial interactions between substituent
groups of PQQ and amino acid residues in the model GDH, many of which
are conserved in MDH (13). Among these residues, Lys-493 and Asn-607
are proposed to make hydrogen bonds with C-4 or C-5 carbonyl oxygen at
the reactive site of PQQ, and Asp-466 is proposed to be involved in the
initiation of glucose oxidation. Therefore, all the above residues are
assumed to be important for the catalytic reaction of GDH. Some
chemical approach (18) and mutagenic analyses (19-21) have been
performed, but the evidence for the proposed catalytic domain structure
and amino acid residues involved in the reaction is still limited.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

View larger version (22K):
[in a new window]
Fig. 1.
Amino acid residues in the active site of the
model GDH. A, the vertical interactions of PQQ with
His-262 and Trp-404. B, the equatorial interactions of PQQ
with Ca2+ and several amino acid residues (reproduced, with
permission, from Ref. 1). Amino acid substitutions were introduced to
His-262, Trp-404, Asn-607, Lys-493, and Asp-466.
Bacterial strains and plasmids

View larger version (55K):
[in a new window]
Fig. 2.
Western blot analysis of the mutant GDHs
obtained by site-specific mutagenesis. The membrane fractions from
YU423 containing pUCGCD1 or pUCGCD mutants, which were used for
estimating enzyme activities as shown in Table II, were subjected to a
SDS-10% polyacrylamide gel electrophoresis and transferred to the blot
membrane. The wild-type and mutant GDHs were visualized using a
polyclonal antibody against E. coli GDH as described
previously (30). The relative amount of GDH proteins were
densitometrically estimated by using Bio-Rad Molecular Imager. YU423
containing pUCGCD1 or pUC118 (19) were used as a positive and negative
control, respectively. Lanes 1-7 and
8-13 represent the membrane fractions from the negative
control (30 µg), the positive control (wild type, 5 µg), the
positive control (2.5 µg), H262A (5 µg), W404A (10 µg), W404F (5 µg), K493A (6 µg), D466N (6 µg), D466E (5 µg), D466A (10 µg),
N607A (8 µg), K493R (5 µg), and the positive control (5 µg),
respectively.
PMS reductase and glucose oxidase activities of mutant GDHs in membrane
fractions and their Km values for PQQ and glucose
PMS and Q-2 reductase activities of purified mutant GDHs and their
Km values for PQQ and glucose

View larger version (33K):
[in a new window]
Fig. 3.
Absolute absorption spectra of purified
wild-type and mutant GDHs from E. coli. The
absorption spectrum was taken of 4.5 µM purified GDHs in
5 mM MOPS (pH 7.0) containing 0.1% alkylglucoside
(Apo-GDH spectra). Holo-enzyme formation was
performed by the addition of 4.5 µM PQQ and 0.5 mM MgCl2 for 20 min at 25 °C. Spectra were
taken of holomerized enzymes (+ PQQ spectra) and
subsequently after the addition of 33 mM glucose, in which
those at 10 s, 30 min, and 60 min are only shown (+ PQQ + Glu spectra). PQQ reduction abilities during glucose oxidation of
mutant GDHs were compared with that of the wild type by their spectral
changes in between 300 and 350 nm. Similar changes of absolute spectra
were reported with membrane-bound apo-GDH from Acinetobacter
calcoaceticus after adding PQQ and PQQ + substrate (37).
-lactone. After that,
Lys-493 hydrogen-bonding with the C-4 and C-5 carbonyl oxygens of PQQ
receives electrons as the first electron acceptor from
PQQH2, which allows PQQ to be back in the initial oxidized form.

View larger version (17K):
[in a new window]
Fig. 4.
A putative catalytic reaction mechanism via a
hemiketal intermediate of GDH in E. coli. Asp-466
initiates the oxidation reaction of glucose by abstraction of a proton
and Lys-493 is involved in PQQH2 oxidation by accepting
electrons. The detailed mechanism is described under "Results and
Discussion." The reaction mechanism is based on experiments on
methanol dehydrogenase described in Ref. 34 and the mechanisms proposed
for methanol dehydrogenase in Refs. 13 and 27.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
To whom correspondence and reprint requests should be addressed:
Dept. of Biological Chemistry, Faculty of Agriculture, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan. Tel./Fax: 81-839-33-5869; E-mail: yamada@agr.yamaguchi-u.ac.jp.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
1.
Goodwin, P. M.,
and Anthony, C.
(1998)
in
Advances in Microbial Physiology
(Poole, R. K., ed), Vol. 40
, pp. 1-80, Academic Press, London
2.
Van Schie, B. J.,
Hellingwerf, K. J.,
van Dijken, J. P.,
Elferink, M. G. L.,
van Dijl, J. M.,
Kuenen, J. G.,
and Konings, W. L.
(1985)
J. Bacteriol.
163,
493-499 3.
Matsushita, K.,
Nonobe, M.,
Shinagawa, E.,
Adachi, O.,
and Ameyama, M.
(1987)
J. Bacteriol.
169,
205-209 4.
Yamada, M.,
Sumi, K.,
Matsushita, K.,
Adachi, O.,
and Yamada, Y.
(1993)
J. Biol. Chem.
268,
12812-12817 5.
Duine, J. A.,
Frank, J.,
and van Zeeland, J. K.
(1979)
FEBS Lett.
108,
443-446[CrossRef][Medline]
[Order article via Infotrieve]
6.
Ameyama, M.,
Matsushita, K.,
Ohno, Y.,
Shinagawa, E.,
and Adachi, O.
(1981)
FEBS Lett.
130,
179-183[CrossRef][Medline]
[Order article via Infotrieve]
7.
Hommes, R. W. J.,
Postma, P. W.,
Neijssel, O. M.,
Tempest, D. W.,
Dokter, P.,
and Duine, J. A.
(1984)
FEMS Microbiol. Lett.
24,
329-333[CrossRef]
8.
Matsushita, K.,
Arents, J. C.,
Bader, R.,
Yamada, M.,
Adachi, O.,
and Postma, P. W.
(1997)
Microbiology
143,
3149-3156[Abstract]
9.
Ameyama, M.,
Nonobe, M.,
Hayashi, M.,
Shinagawa, E.,
Matsushita, K.,
and Adachi, O.
(1985)
Agric. Biol. Chem.
49,
1227-1231
10.
Xia, Z.-X.,
Dai, W.-W.,
Xiong, J.-P.,
Hao, Z.-P.,
Davidson, V. L.,
White, S.,
and Mathews, F. S.
(1992)
J. Biol. Chem.
267,
22289-22297 11.
Ghosh, M.,
Anthony, C.,
Harlos, K.,
Goodwin, M. G.,
and Blake, C. C. F.
(1995)
Structure
3,
177-187[Medline]
[Order article via Infotrieve]
12.
Xia, Z.,
Dai, W.,
Zhang, Y.,
White, S. A.,
Boyd, G. D.,
and Mathews, F. S.
(1996)
J. Mol. Biol.
259,
480-501[CrossRef][Medline]
[Order article via Infotrieve]
13.
Cozier, G. E.,
and Anthony, C.
(1995)
Biochem. J.
312,
679-685
14.
Duine, J. A.,
Frank, J.,
and Jongejan, J. A.
(1983)
Anal. Biochem.
133,
239-243[CrossRef][Medline]
[Order article via Infotrieve]
15.
Duine, J. A.,
Frank, J.,
and Jongejan, J. A.
(1987)
Adv. Enzymol.
59,
169-212
16.
Duine, J. A.
(1991)
Eur. J. Biochem.
200,
271-284[Medline]
[Order article via Infotrieve]
17.
Blake, C. C. F.,
Ghosh, M.,
Harlos, K.,
Avezoux, A.,
and Anthony, C.
(1994)
Nat. Struct. Biol.
1,
102-105[CrossRef][Medline]
[Order article via Infotrieve]
18.
Imanaga, Y.
(1989)
in
PQQ and Quinoproteins
(Jongejan, J. A.
, and Duine, J. A., eds)
, pp. 87-96, Kluwer Academic Publishers, Dordrecht, The Netherlands
19.
Yamada, M.,
Inbe, H.,
Tanaka, M.,
Sumi, K.,
Matsushita, K.,
and Adachi, O.
(1998)
J. Biol. Chem.
273,
22021-22027 20.
Sode, K.,
and Kojima, K.
(1997)
Biotechnol. Lett.
19,
1073-1077[CrossRef]
21.
Cozier, G. E.,
Salleh, R. A.,
and Anthony, C.
(1999)
Biochem. J.
340,
639-647
22.
Braun, M.,
Bungert, S.,
and Friedrich, T.
(1998)
Biochemistry
37,
1861-1867[CrossRef][Medline]
[Order article via Infotrieve]
23.
Nakamura, K.,
Yamaki, M.,
Sarada, M.,
Nakayama, S.,
Vibat, CR.,
Gennis, RB.,
Nakayashiki, T.,
Inokuchi, H.,
Kojima, S.,
and Kita, K.
(1996)
J. Biol. Chem.
271,
521-527 24.
Machlin, S. M.,
and Hanson, R. S.
(1988)
J. Bacteriol.
170,
4739-4747 25.
Anthony, C.,
Chan, H. T. C.,
Cox, J. M.,
and Richardson, I. W.
(1993)
in
Microbial Growth on C1 Compounds
(Murrell, J. C.
, and Kelly, D. P., eds)
, pp. 221-223, Intercept Ltd., Andover, United Kingdom
26.
Matsushita, K.,
Yakushi, T.,
Toyama, H.,
Shinagawa, E.,
and Adachi, O.
(1996)
J. Biol. Chem.
271,
4850-4857 27.
Anthony, C.
(1996)
Biochem. J.
320,
697-711
28.
Sanger, F.,
Nicklen, S.,
and Coulson, A. R.
(1977)
Proc. Natl. Acad. Sci. U. S. A.
74,
5463-5467 29.
Maniatis, T.,
Fritsch, E. F.,
and Sambrook, J.
(1982)
Molecular Cloning: A Laboratory Manual
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
30.
Matsudaira, P.
(1987)
J. Biol. Chem.
262,
10035-10038 31.
Matsushita, K.,
Shinagawa, E.,
Adachi, O.,
and Ameyama, M.
(1989)
J. Biochem. (Tokyo)
105,
633-637 32.
Dulley, J. R.,
and Grieve, P. A.
(1975)
Anal. Biochem.
64,
136-141[CrossRef][Medline]
[Order article via Infotrieve]
33.
Anthony, C.
(1998)
in
Comprehensive Biological Catalysis: A Mechanistic Reference
(Sinnott, M., ed)
, pp. 155-180, Academic Press, London
34.
Frank, J.,
van Krimpen, S. H.,
Verwiel, P. E. J.,
Jongejan, J. A.,
Mulder, A. C.,
and Duine, J. A.
(1989)
Eur. J. Biochem.
184,
187-195[Medline]
[Order article via Infotrieve]
35.
Anthony, C.,
Ghosh, M.,
and Blake, C. C. F.
(1994)
Biochem. J.
304,
665-674
36.
Itoh, S.,
Kawakami, H.,
and Fukuzumi, A.
(1997)
J. Am. Chem. Soc.
119,
439-440[CrossRef]
37.
Matsushita, K.,
Toyama, H.,
Ameyama, M.,
Adachi, O.,
Dewanti, A.,
and Duine, J. A.
(1995)
Biosci. Biotech. Biochem.
59,
1548-1555
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
G. Mustafa, C. T. Migita, Y. Ishikawa, K. Kobayashi, S. Tagawa, and M. Yamada Menaquinone as Well as Ubiquinone as a Bound Quinone Crucial for Catalytic Activity and Intramolecular Electron Transfer in Escherichia coli Membrane-bound Glucose Dehydrogenase J. Biol. Chem., October 17, 2008; 283(42): 28169 - 28175. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mustafa, Y. Ishikawa, K. Kobayashi, C. T. Migita, M. D. Elias, S. Nakamura, S. Tagawa, and M. Yamada Amino Acid Residues Interacting with Both the Bound Quinone and Coenzyme, Pyrroloquinoline Quinone, in Escherichia coli Membrane-bound Glucose Dehydrogenase J. Biol. Chem., August 8, 2008; 283(32): 22215 - 22221. [Abstract] [Full Text] [PDF] |
||||
![]() |
MD. Elias, S. Nakamura, C. T. Migita, H. Miyoshi, H. Toyama, K. Matsushita, O. Adachi, and M. Yamada Occurrence of a Bound Ubiquinone and Its Function in Escherichia coli Membrane-bound Quinoprotein Glucose Dehydrogenase J. Biol. Chem., January 23, 2004; 279(4): 3078 - 3083. [Abstract] [Full Text] [PDF] |
||||
![]() |
MD. Elias, M. Tanaka, M. Sakai, H. Toyama, K. Matsushita, O. Adachi, and M. Yamada C-terminal Periplasmic Domain of Escherichia coli Quinoprotein Glucose Dehydrogenase Transfers Electrons to Ubiquinone J. Biol. Chem., December 14, 2001; 276(51): 48356 - 48361. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |